Rachel Klemovitch, Assistant Editor06.19.24
Curiteva has announced the commercial launch of Inspire Posterior Interbody Fusion Solutions. Inspired is an FDA-cleared solution designed to enhance patient outcomes of transforaminal lumbar procedures.
The Inspire Technology will be featured at the State of Spine Surgery Think Tank in San Jose del Cabo, Mexico.
“The commercialization of our Inspire TLIF implant underscores our commitment to integrating the revolutionary Inspire technology across all of our implant solutions,” said Mark Mohlman, Curiteva’s Executive Vice President.
The Inspire 3D Printed Trabecular PEEK TLIF implant is available in a variety of implant sizes. It uses HAFUSE Technology for an optimized interconnected porous structure, promoting bone ingrowth into and through the entire device.
Kevin Foley, MD, Chairman of Semmes-Murphey Neurologic and Spine Institute, said, “Being able to maximize bone ingrowth is critical to the success of the fusion process. This innovative technology is poised to elevate the standard of patient care through its advanced design and superior biomechanical properties.”
The Inspire platform is manufactured utilizing the Evonik VESTAKEEP i4 3DF PEEK high-performance polymer on a proprietary, patented 3D printer designed, programmed, and built by Curiteva.
Eric Linder, founder and Chief Technology Officer for Curiteva, commented, “The launch of the Inspire TLIF System is a critically significant triumph for Curiteva as we achieve yet another first-in-industry milestone. The commitment we have made in developing the innovative Inspire technology has resulted in rapid technological advancement which supports our mission to advance the quality of orthopedic care.”
The Inspire Technology will be featured at the State of Spine Surgery Think Tank in San Jose del Cabo, Mexico.
“The commercialization of our Inspire TLIF implant underscores our commitment to integrating the revolutionary Inspire technology across all of our implant solutions,” said Mark Mohlman, Curiteva’s Executive Vice President.
The Inspire 3D Printed Trabecular PEEK TLIF implant is available in a variety of implant sizes. It uses HAFUSE Technology for an optimized interconnected porous structure, promoting bone ingrowth into and through the entire device.
Kevin Foley, MD, Chairman of Semmes-Murphey Neurologic and Spine Institute, said, “Being able to maximize bone ingrowth is critical to the success of the fusion process. This innovative technology is poised to elevate the standard of patient care through its advanced design and superior biomechanical properties.”
The Inspire platform is manufactured utilizing the Evonik VESTAKEEP i4 3DF PEEK high-performance polymer on a proprietary, patented 3D printer designed, programmed, and built by Curiteva.
Eric Linder, founder and Chief Technology Officer for Curiteva, commented, “The launch of the Inspire TLIF System is a critically significant triumph for Curiteva as we achieve yet another first-in-industry milestone. The commitment we have made in developing the innovative Inspire technology has resulted in rapid technological advancement which supports our mission to advance the quality of orthopedic care.”